Skip to content

Clinical study on the Prevention of recurrence of choledocholithiasis after ERCP with Lidan Xiaoshi Mixture

Clinical study on the Prevention of recurrence of choledocholithiasis after ERCP with Lidan Xiaoshi Mixture

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003910
Enrollment
Unknown
Registered
2020-09-08
Start date
2020-09-03
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choledocholithiasis

Interventions

Sponsors

Dongfang Hospital University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients who were diagnosed as primary choledocholithiasis by first-line examination (laboratory examination + B-ultrasound) and / or second-line examination (CT or MRCP) and successfully completed ERCP lithotomy; 2. Patients aged from 18 to 70 years old; 3. Patients who did not take choleretic drugs within one month before operation.

Exclusion criteria

Exclusion criteria: 1. Patients without choledocholithiasis or unsuccessful choledocholithotomy; 2. Patients with biliary stricture; 3. Patients with non primary choledocholithiasis such as cholecystolithiasis and hepatolithiasis; 4. Patients with mental illness; 5. Patients with other serious chronic diseases; 6. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
The recurrence rate;

Secondary

MeasureTime frame
Bile biochemistry;

Countries

China

Contacts

Public ContactZhang Liping

Beijing Univercity of Chinese Medicine

lpzhang2005@126.com+86 13911216028

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026